Dear User,

 

The CCPN Executive Committee has set new priorities for CCPN in the coming year having taken into consideration feedback from users and the Scientific Advisory Board. We consider it essential that CCPN should produce a new Analysis version by autumn or winter 2011.

 

The new version should be:

 

- More streamlined and intuitive to use

- Easier for new users to get up-and-running

- At least as capable as the current version

- Familiar to existing users

- Less cluttered and more automatic

- Faster and nicer looking

- Well integrated with external programs for assignment, structure

  generation and validation, mainly through the WeNMR project

- Linked to a workflow and project tracking system

 

In order to have time for this effort, the CCPN programming team must reduce its time spent on other activities to an absolute minimum. This means adding no new features and encouraging work-around options to complicated bug fixes.  They will honour any prearranged courses and workshops but no further commitment in this area is possible until after the next release.

 

This change in emphasis is important for the future of CCPN Analysis and the new 2011 version of the software will benefit the whole NMR community.  Your co-operation in allowing the programmers fulfil this task is appreciated, together with your continual support for the project.

 

If you are interested in being an alpha tester for the new Analysis, and are willing to do a certain amount of supportive work, please let me know.  We are especially interested in people with little or no Analysis experience and those who have worked primarily with competitor packages such as Sparky or NMRView.

 

Please contact me if you have any questions.

 

Regards

 

Mark Howard

 

Chair, CCPN Executive Committee.

 

================================================

Dr. Mark J. Howard CSci CChem MRSC

Senior Lecturer in Biomolecular NMR Spectroscopy

School of Biosciences

University of Kent

Canterbury, Kent, CT2 7NJ, UK.

================================================